Nigericin Abrogates Maternal and Embryonic Oxidative Stress in the Streptozotocin-Induced Diabetic Pregnant Rats
Hyperglycemic exposure in diabetic pregnancy can lead to many developmental changes, such as delayed development, fetal malformations, and fetal/embryo death. These detrimental complications are collectively known as diabetic embryopathy or teratogenesis. The current study focuses to discover the th...
Gespeichert in:
Veröffentlicht in: | Applied biochemistry and biotechnology 2023-02, Vol.195 (2), p.801-815 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 815 |
---|---|
container_issue | 2 |
container_start_page | 801 |
container_title | Applied biochemistry and biotechnology |
container_volume | 195 |
creator | Guo, Huitao Zhang, Qiuyan Li, Rui Seshadri, Vidya Devanathadesikan |
description | Hyperglycemic exposure in diabetic pregnancy can lead to many developmental changes, such as delayed development, fetal malformations, and fetal/embryo death. These detrimental complications are collectively known as diabetic embryopathy or teratogenesis. The current study focuses to discover the therapeutic properties of the nigericin against the STZ-stimulated diabetic embryopathy via alleviation of maternal and embryonic oxidative stress. The male and female rats at a 1:1 ratio were permitted to mate overnight to establish the course of pregnancy. The pregnant rats were distributed into four groups control, diabetic pregnant (via administering 40 mg/kg of STZ), and diabetic + 10 and 20 mg/kg of nigericin-administered (via oral gavage from days 5 to 12) groups, respectively. The glucose level, urine output, diet intake, and body weight were determined carefully. The embryo and placenta weight and implantation rates were examined, and data were tabulated. The total protein and lipid profiles were assessed using respective kits. The oxidative stress markers and antioxidant enzymes were examined using respective assay kits. The 10 and 20 mg/kg of nigericin treatment decreased the glucose level and urine output and improved the diet intake and body weight gain in diabetic pregnant rats. The nigericin also decreased the total protein, cholesterol, triglycerides, and very-low-density lipoprotein (VLDL) and improved the high-density lipoprotein (HDL) in the serum of pregnant rats. The levels of malondialdehyde (MDA), reactive oxygen species (ROS), and protein carbonyls were decreased by the nigericin in both liver and embryos of the pregnant rats. The levels of glutathione (GSH), total thiols, and activities of catalase (CAT), glutathione reductase (GR), superoxide dismutase (SOD), glutathione peroxidase (GPX), and glutathione S-transferase (GST) were improved by the nigericin in the diabetic pregnant rats. Altogether, these results provide evidence that nigericin treatment remarkably attenuates the diabetes-stimulated embryopathy in rats. The nigericin effectively decreased embryo lethality, reduced glucose and dyslipidemia, and relieves oxidative stress via upregulating the antioxidant enzyme activities. Hence, it can be a talented therapeutic agent to treat diabetic pregnancy-associated complications. |
doi_str_mv | 10.1007/s12010-022-04100-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2766912440</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2766912440</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-a7b22bc1c185e4c383bfbfa369aa1fcf59d885e56e8e76cd8d306de47b7de5813</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EoqXwAyyQJdYBPxI7WValQKVCEY-15VdKqjYptoMoX49LCuzYjDUz996RDwCnGF1ghPilxwRhlCBCEpTGScL2QB9nWRFHBd4HfUQ4TQjJix448n6BECZ5xg9BjzJcIJamfbC-r-bWVbqq4VC5Zi6D9fAuVlfLJZS1geOVcpumrjScfVRGhurdwqfgrPcwmsJr161D89mEJuYkk9q02hp4VUllQ_Q9ODuvZR3gowz-GByUcuntye4dgJfr8fPoNpnObiaj4TTRlGchkVwRojTWOM9sqmlOValKSVkhJS51mRUmj5uM2dxypk1uKGLGplxxY7Mc0wE473LXrnlrrQ9i0bTbT3lBOGMFJmmKoop0Ku0a750txdpVK-k2AiOxhSw6yCJCFt-QBYums110q1bW_Fp-qEYB7QQ-rurI9-_2P7FfZYCJJg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2766912440</pqid></control><display><type>article</type><title>Nigericin Abrogates Maternal and Embryonic Oxidative Stress in the Streptozotocin-Induced Diabetic Pregnant Rats</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Guo, Huitao ; Zhang, Qiuyan ; Li, Rui ; Seshadri, Vidya Devanathadesikan</creator><creatorcontrib>Guo, Huitao ; Zhang, Qiuyan ; Li, Rui ; Seshadri, Vidya Devanathadesikan</creatorcontrib><description>Hyperglycemic exposure in diabetic pregnancy can lead to many developmental changes, such as delayed development, fetal malformations, and fetal/embryo death. These detrimental complications are collectively known as diabetic embryopathy or teratogenesis. The current study focuses to discover the therapeutic properties of the nigericin against the STZ-stimulated diabetic embryopathy via alleviation of maternal and embryonic oxidative stress. The male and female rats at a 1:1 ratio were permitted to mate overnight to establish the course of pregnancy. The pregnant rats were distributed into four groups control, diabetic pregnant (via administering 40 mg/kg of STZ), and diabetic + 10 and 20 mg/kg of nigericin-administered (via oral gavage from days 5 to 12) groups, respectively. The glucose level, urine output, diet intake, and body weight were determined carefully. The embryo and placenta weight and implantation rates were examined, and data were tabulated. The total protein and lipid profiles were assessed using respective kits. The oxidative stress markers and antioxidant enzymes were examined using respective assay kits. The 10 and 20 mg/kg of nigericin treatment decreased the glucose level and urine output and improved the diet intake and body weight gain in diabetic pregnant rats. The nigericin also decreased the total protein, cholesterol, triglycerides, and very-low-density lipoprotein (VLDL) and improved the high-density lipoprotein (HDL) in the serum of pregnant rats. The levels of malondialdehyde (MDA), reactive oxygen species (ROS), and protein carbonyls were decreased by the nigericin in both liver and embryos of the pregnant rats. The levels of glutathione (GSH), total thiols, and activities of catalase (CAT), glutathione reductase (GR), superoxide dismutase (SOD), glutathione peroxidase (GPX), and glutathione S-transferase (GST) were improved by the nigericin in the diabetic pregnant rats. Altogether, these results provide evidence that nigericin treatment remarkably attenuates the diabetes-stimulated embryopathy in rats. The nigericin effectively decreased embryo lethality, reduced glucose and dyslipidemia, and relieves oxidative stress via upregulating the antioxidant enzyme activities. Hence, it can be a talented therapeutic agent to treat diabetic pregnancy-associated complications.</description><identifier>ISSN: 0273-2289</identifier><identifier>EISSN: 1559-0291</identifier><identifier>DOI: 10.1007/s12010-022-04100-6</identifier><identifier>PMID: 36190644</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Antioxidants ; Antioxidants - pharmacology ; Biochemistry ; Biotechnology ; Blood Glucose - metabolism ; Body Weight ; Body weight gain ; Carbonyl compounds ; Carbonyls ; Catalase ; Catalase - metabolism ; Chemical compounds ; Chemistry ; Chemistry and Materials Science ; Cholesterol ; Density ; Diabetes ; Diabetes mellitus ; Diabetes Mellitus, Experimental - metabolism ; Diet ; Dyslipidemia ; Embryos ; Enzymatic activity ; Female ; Fetal Diseases ; Fetuses ; Glucose ; Glutathione ; Glutathione - metabolism ; Glutathione peroxidase ; Glutathione reductase ; Glutathione transferase ; Humans ; Implantation ; Lethality ; Lipids ; Lipoproteins (very low density) ; Male ; Metabolic disorders ; Nigericin ; Nigericin - adverse effects ; Original Article ; Oxidative Stress ; Peroxidase ; Pharmacology ; Pregnancy ; Pregnancy complications ; Proteins ; Rats ; Rats, Wistar ; Reactive oxygen species ; Reductases ; Streptozocin ; Streptozocin - adverse effects ; Superoxide dismutase ; Superoxide Dismutase - metabolism ; Teratogenesis ; Teratogenicity ; Thiols ; Triglycerides</subject><ispartof>Applied biochemistry and biotechnology, 2023-02, Vol.195 (2), p.801-815</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-a7b22bc1c185e4c383bfbfa369aa1fcf59d885e56e8e76cd8d306de47b7de5813</citedby><cites>FETCH-LOGICAL-c375t-a7b22bc1c185e4c383bfbfa369aa1fcf59d885e56e8e76cd8d306de47b7de5813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12010-022-04100-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12010-022-04100-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36190644$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guo, Huitao</creatorcontrib><creatorcontrib>Zhang, Qiuyan</creatorcontrib><creatorcontrib>Li, Rui</creatorcontrib><creatorcontrib>Seshadri, Vidya Devanathadesikan</creatorcontrib><title>Nigericin Abrogates Maternal and Embryonic Oxidative Stress in the Streptozotocin-Induced Diabetic Pregnant Rats</title><title>Applied biochemistry and biotechnology</title><addtitle>Appl Biochem Biotechnol</addtitle><addtitle>Appl Biochem Biotechnol</addtitle><description>Hyperglycemic exposure in diabetic pregnancy can lead to many developmental changes, such as delayed development, fetal malformations, and fetal/embryo death. These detrimental complications are collectively known as diabetic embryopathy or teratogenesis. The current study focuses to discover the therapeutic properties of the nigericin against the STZ-stimulated diabetic embryopathy via alleviation of maternal and embryonic oxidative stress. The male and female rats at a 1:1 ratio were permitted to mate overnight to establish the course of pregnancy. The pregnant rats were distributed into four groups control, diabetic pregnant (via administering 40 mg/kg of STZ), and diabetic + 10 and 20 mg/kg of nigericin-administered (via oral gavage from days 5 to 12) groups, respectively. The glucose level, urine output, diet intake, and body weight were determined carefully. The embryo and placenta weight and implantation rates were examined, and data were tabulated. The total protein and lipid profiles were assessed using respective kits. The oxidative stress markers and antioxidant enzymes were examined using respective assay kits. The 10 and 20 mg/kg of nigericin treatment decreased the glucose level and urine output and improved the diet intake and body weight gain in diabetic pregnant rats. The nigericin also decreased the total protein, cholesterol, triglycerides, and very-low-density lipoprotein (VLDL) and improved the high-density lipoprotein (HDL) in the serum of pregnant rats. The levels of malondialdehyde (MDA), reactive oxygen species (ROS), and protein carbonyls were decreased by the nigericin in both liver and embryos of the pregnant rats. The levels of glutathione (GSH), total thiols, and activities of catalase (CAT), glutathione reductase (GR), superoxide dismutase (SOD), glutathione peroxidase (GPX), and glutathione S-transferase (GST) were improved by the nigericin in the diabetic pregnant rats. Altogether, these results provide evidence that nigericin treatment remarkably attenuates the diabetes-stimulated embryopathy in rats. The nigericin effectively decreased embryo lethality, reduced glucose and dyslipidemia, and relieves oxidative stress via upregulating the antioxidant enzyme activities. Hence, it can be a talented therapeutic agent to treat diabetic pregnancy-associated complications.</description><subject>Animals</subject><subject>Antioxidants</subject><subject>Antioxidants - pharmacology</subject><subject>Biochemistry</subject><subject>Biotechnology</subject><subject>Blood Glucose - metabolism</subject><subject>Body Weight</subject><subject>Body weight gain</subject><subject>Carbonyl compounds</subject><subject>Carbonyls</subject><subject>Catalase</subject><subject>Catalase - metabolism</subject><subject>Chemical compounds</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Cholesterol</subject><subject>Density</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus, Experimental - metabolism</subject><subject>Diet</subject><subject>Dyslipidemia</subject><subject>Embryos</subject><subject>Enzymatic activity</subject><subject>Female</subject><subject>Fetal Diseases</subject><subject>Fetuses</subject><subject>Glucose</subject><subject>Glutathione</subject><subject>Glutathione - metabolism</subject><subject>Glutathione peroxidase</subject><subject>Glutathione reductase</subject><subject>Glutathione transferase</subject><subject>Humans</subject><subject>Implantation</subject><subject>Lethality</subject><subject>Lipids</subject><subject>Lipoproteins (very low density)</subject><subject>Male</subject><subject>Metabolic disorders</subject><subject>Nigericin</subject><subject>Nigericin - adverse effects</subject><subject>Original Article</subject><subject>Oxidative Stress</subject><subject>Peroxidase</subject><subject>Pharmacology</subject><subject>Pregnancy</subject><subject>Pregnancy complications</subject><subject>Proteins</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reactive oxygen species</subject><subject>Reductases</subject><subject>Streptozocin</subject><subject>Streptozocin - adverse effects</subject><subject>Superoxide dismutase</subject><subject>Superoxide Dismutase - metabolism</subject><subject>Teratogenesis</subject><subject>Teratogenicity</subject><subject>Thiols</subject><subject>Triglycerides</subject><issn>0273-2289</issn><issn>1559-0291</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kMtOwzAQRS0EoqXwAyyQJdYBPxI7WValQKVCEY-15VdKqjYptoMoX49LCuzYjDUz996RDwCnGF1ghPilxwRhlCBCEpTGScL2QB9nWRFHBd4HfUQ4TQjJix448n6BECZ5xg9BjzJcIJamfbC-r-bWVbqq4VC5Zi6D9fAuVlfLJZS1geOVcpumrjScfVRGhurdwqfgrPcwmsJr161D89mEJuYkk9q02hp4VUllQ_Q9ODuvZR3gowz-GByUcuntye4dgJfr8fPoNpnObiaj4TTRlGchkVwRojTWOM9sqmlOValKSVkhJS51mRUmj5uM2dxypk1uKGLGplxxY7Mc0wE473LXrnlrrQ9i0bTbT3lBOGMFJmmKoop0Ku0a750txdpVK-k2AiOxhSw6yCJCFt-QBYums110q1bW_Fp-qEYB7QQ-rurI9-_2P7FfZYCJJg</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Guo, Huitao</creator><creator>Zhang, Qiuyan</creator><creator>Li, Rui</creator><creator>Seshadri, Vidya Devanathadesikan</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7ST</scope><scope>7T7</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>SOI</scope></search><sort><creationdate>20230201</creationdate><title>Nigericin Abrogates Maternal and Embryonic Oxidative Stress in the Streptozotocin-Induced Diabetic Pregnant Rats</title><author>Guo, Huitao ; Zhang, Qiuyan ; Li, Rui ; Seshadri, Vidya Devanathadesikan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-a7b22bc1c185e4c383bfbfa369aa1fcf59d885e56e8e76cd8d306de47b7de5813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Antioxidants</topic><topic>Antioxidants - pharmacology</topic><topic>Biochemistry</topic><topic>Biotechnology</topic><topic>Blood Glucose - metabolism</topic><topic>Body Weight</topic><topic>Body weight gain</topic><topic>Carbonyl compounds</topic><topic>Carbonyls</topic><topic>Catalase</topic><topic>Catalase - metabolism</topic><topic>Chemical compounds</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Cholesterol</topic><topic>Density</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus, Experimental - metabolism</topic><topic>Diet</topic><topic>Dyslipidemia</topic><topic>Embryos</topic><topic>Enzymatic activity</topic><topic>Female</topic><topic>Fetal Diseases</topic><topic>Fetuses</topic><topic>Glucose</topic><topic>Glutathione</topic><topic>Glutathione - metabolism</topic><topic>Glutathione peroxidase</topic><topic>Glutathione reductase</topic><topic>Glutathione transferase</topic><topic>Humans</topic><topic>Implantation</topic><topic>Lethality</topic><topic>Lipids</topic><topic>Lipoproteins (very low density)</topic><topic>Male</topic><topic>Metabolic disorders</topic><topic>Nigericin</topic><topic>Nigericin - adverse effects</topic><topic>Original Article</topic><topic>Oxidative Stress</topic><topic>Peroxidase</topic><topic>Pharmacology</topic><topic>Pregnancy</topic><topic>Pregnancy complications</topic><topic>Proteins</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reactive oxygen species</topic><topic>Reductases</topic><topic>Streptozocin</topic><topic>Streptozocin - adverse effects</topic><topic>Superoxide dismutase</topic><topic>Superoxide Dismutase - metabolism</topic><topic>Teratogenesis</topic><topic>Teratogenicity</topic><topic>Thiols</topic><topic>Triglycerides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guo, Huitao</creatorcontrib><creatorcontrib>Zhang, Qiuyan</creatorcontrib><creatorcontrib>Li, Rui</creatorcontrib><creatorcontrib>Seshadri, Vidya Devanathadesikan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Environment Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>Environment Abstracts</collection><jtitle>Applied biochemistry and biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guo, Huitao</au><au>Zhang, Qiuyan</au><au>Li, Rui</au><au>Seshadri, Vidya Devanathadesikan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nigericin Abrogates Maternal and Embryonic Oxidative Stress in the Streptozotocin-Induced Diabetic Pregnant Rats</atitle><jtitle>Applied biochemistry and biotechnology</jtitle><stitle>Appl Biochem Biotechnol</stitle><addtitle>Appl Biochem Biotechnol</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>195</volume><issue>2</issue><spage>801</spage><epage>815</epage><pages>801-815</pages><issn>0273-2289</issn><eissn>1559-0291</eissn><abstract>Hyperglycemic exposure in diabetic pregnancy can lead to many developmental changes, such as delayed development, fetal malformations, and fetal/embryo death. These detrimental complications are collectively known as diabetic embryopathy or teratogenesis. The current study focuses to discover the therapeutic properties of the nigericin against the STZ-stimulated diabetic embryopathy via alleviation of maternal and embryonic oxidative stress. The male and female rats at a 1:1 ratio were permitted to mate overnight to establish the course of pregnancy. The pregnant rats were distributed into four groups control, diabetic pregnant (via administering 40 mg/kg of STZ), and diabetic + 10 and 20 mg/kg of nigericin-administered (via oral gavage from days 5 to 12) groups, respectively. The glucose level, urine output, diet intake, and body weight were determined carefully. The embryo and placenta weight and implantation rates were examined, and data were tabulated. The total protein and lipid profiles were assessed using respective kits. The oxidative stress markers and antioxidant enzymes were examined using respective assay kits. The 10 and 20 mg/kg of nigericin treatment decreased the glucose level and urine output and improved the diet intake and body weight gain in diabetic pregnant rats. The nigericin also decreased the total protein, cholesterol, triglycerides, and very-low-density lipoprotein (VLDL) and improved the high-density lipoprotein (HDL) in the serum of pregnant rats. The levels of malondialdehyde (MDA), reactive oxygen species (ROS), and protein carbonyls were decreased by the nigericin in both liver and embryos of the pregnant rats. The levels of glutathione (GSH), total thiols, and activities of catalase (CAT), glutathione reductase (GR), superoxide dismutase (SOD), glutathione peroxidase (GPX), and glutathione S-transferase (GST) were improved by the nigericin in the diabetic pregnant rats. Altogether, these results provide evidence that nigericin treatment remarkably attenuates the diabetes-stimulated embryopathy in rats. The nigericin effectively decreased embryo lethality, reduced glucose and dyslipidemia, and relieves oxidative stress via upregulating the antioxidant enzyme activities. Hence, it can be a talented therapeutic agent to treat diabetic pregnancy-associated complications.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>36190644</pmid><doi>10.1007/s12010-022-04100-6</doi><tpages>15</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0273-2289 |
ispartof | Applied biochemistry and biotechnology, 2023-02, Vol.195 (2), p.801-815 |
issn | 0273-2289 1559-0291 |
language | eng |
recordid | cdi_proquest_journals_2766912440 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Animals Antioxidants Antioxidants - pharmacology Biochemistry Biotechnology Blood Glucose - metabolism Body Weight Body weight gain Carbonyl compounds Carbonyls Catalase Catalase - metabolism Chemical compounds Chemistry Chemistry and Materials Science Cholesterol Density Diabetes Diabetes mellitus Diabetes Mellitus, Experimental - metabolism Diet Dyslipidemia Embryos Enzymatic activity Female Fetal Diseases Fetuses Glucose Glutathione Glutathione - metabolism Glutathione peroxidase Glutathione reductase Glutathione transferase Humans Implantation Lethality Lipids Lipoproteins (very low density) Male Metabolic disorders Nigericin Nigericin - adverse effects Original Article Oxidative Stress Peroxidase Pharmacology Pregnancy Pregnancy complications Proteins Rats Rats, Wistar Reactive oxygen species Reductases Streptozocin Streptozocin - adverse effects Superoxide dismutase Superoxide Dismutase - metabolism Teratogenesis Teratogenicity Thiols Triglycerides |
title | Nigericin Abrogates Maternal and Embryonic Oxidative Stress in the Streptozotocin-Induced Diabetic Pregnant Rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T08%3A11%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nigericin%20Abrogates%20Maternal%20and%20Embryonic%20Oxidative%20Stress%20in%20the%20Streptozotocin-Induced%20Diabetic%20Pregnant%20Rats&rft.jtitle=Applied%20biochemistry%20and%20biotechnology&rft.au=Guo,%20Huitao&rft.date=2023-02-01&rft.volume=195&rft.issue=2&rft.spage=801&rft.epage=815&rft.pages=801-815&rft.issn=0273-2289&rft.eissn=1559-0291&rft_id=info:doi/10.1007/s12010-022-04100-6&rft_dat=%3Cproquest_cross%3E2766912440%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2766912440&rft_id=info:pmid/36190644&rfr_iscdi=true |